BLOOD CELL TECHNOLOGIES LLC
SETAUKET, United States · Founded 2015 · $5.0M raised
- Headquarters
- SETAUKET, New York
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2G
- Total Funding
- $5.0M
- Last Round
- $5.0M GrantJan 2017
- Rounds
- 2
About
Blood Cell Technologies, LLC is a Setauket, New York biotech company focused on hematology drug discovery, particularly the development of BLVRB inhibitors for treating chemotherapy-induced thrombocytopenia. The company has received multiple NIH SBIR awards from the Department of Health and Human Services and conducts R&D led by Chief Scientific Officer Natasha M. Nesbitt, PhD.
Summary
BLOOD CELL TECHNOLOGIES LLC is a Biotech company based in SETAUKET, United States, founded in 2015. It has raised $5.0M in total across 2 rounds, most recently a $5.0M Grant round in Jan 2017. Investors include NIH.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2017
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.